The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 3, 2026 | Lerner Teena | Director | Disposed to issuer(D) | 23K | — | — |
| Feb 3, 2026 | Lerner Teena | Director | Tender(U) | 83K | — | — |
| Feb 3, 2026 | Lerner Teena | Director | Disposed to issuer(D) | 200K | — | — |
| Feb 3, 2026 | Lerner Teena | Director | Disposed to issuer(D) | 24K | — | — |
| Feb 3, 2026 | Lerner Teena | Director | Disposed to issuer(D) | 20K | — | — |
| Feb 3, 2026 | Lerner Teena | Director | Disposed to issuer(D) | 10K | — | — |
| Feb 3, 2026 | Lerner Teena | Director | Disposed to issuer(D) | 17K | — | — |
| Feb 3, 2026 | Lerner Teena | Director | Disposed to issuer(D) | 17K | — | — |
| Feb 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | Tender(U) | 61K | — | — |
| Feb 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | Disposed to issuer(D) | 1.2M | — | — |
| Feb 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | Disposed to issuer(D) | 20K | — | — |
| Feb 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | Disposed to issuer(D) | 5K | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Disposed to issuer(D) | 2.4M | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Tender(U) | 153K | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Disposed to issuer(D) | 10K | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Disposed to issuer(D) | 41K | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Disposed to issuer(D) | 150K | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Disposed to issuer(D) | 17K | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Disposed to issuer(D) | 17K | — | — |
| Feb 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Disposed to issuer(D) | 20K | — | — |
| Feb 3, 2026 | Skyler Jay S | Director | Disposed to issuer(D) | 23K | — | — |
| Feb 3, 2026 | Skyler Jay S | Director | Tender(U) | 43K | — | — |
| Feb 3, 2026 | Skyler Jay S | Director | Disposed to issuer(D) | 10K | — | — |
| Feb 3, 2026 | Skyler Jay S | Director | Disposed to issuer(D) | 200K | — | — |
| Feb 3, 2026 | Skyler Jay S | Director | Disposed to issuer(D) | 20K | — | — |
| Feb 3, 2026 | Skyler Jay S | Director | Disposed to issuer(D) | 17K | — | — |
| Feb 3, 2026 | Skyler Jay S | Director | Disposed to issuer(D) | 17K | — | — |
| Feb 3, 2026 | Chinoporos Constantine | See Remarks | Tender(U) | 57K | — | — |
| Feb 3, 2026 | Chinoporos Constantine | See Remarks | Disposed to issuer(D) | 1.0M | — | — |
| Feb 3, 2026 | Hooks Corwin Dale | Chief Commercial Officer | Disposed to issuer(D) | 863K | — | — |
| Feb 3, 2026 | Hooks Corwin Dale | Chief Commercial Officer | Tender(U) | 6K | — | — |
| Feb 3, 2026 | Kanter Stacy J. | Director | Tender(U) | 43K | — | — |
| Feb 3, 2026 | Kanter Stacy J. | Director | Disposed to issuer(D) | 23K | — | — |
| Feb 3, 2026 | Kanter Stacy J. | Director | Disposed to issuer(D) | 10K | — | — |
| Feb 3, 2026 | Kanter Stacy J. | Director | Disposed to issuer(D) | 200K | — | — |
| Feb 3, 2026 | Kanter Stacy J. | Director | Disposed to issuer(D) | 20K | — | — |
| Feb 3, 2026 | Kanter Stacy J. | Director | Disposed to issuer(D) | 17K | — | — |
| Feb 3, 2026 | Kanter Stacy J. | Director | Disposed to issuer(D) | 17K | — | — |
| Jan 1, 2026 | Funtleyder Leslie D. | Chief Financial Officer, Director | Grant(A) | 150K | — | $0 |
| Dec 19, 2025 | Bailey Evan Prescott | Chief Medical Officer | Grant(A) | 438K | — | $0 |
| Dec 19, 2025 | Funtleyder Leslie D. | Chief Financial Officer, Director | Grant(A) | 1.2M | — | $0 |
| Dec 19, 2025 | Chinoporos Constantine | See Remarks | Grant(A) | 438K | — | $0 |
| Dec 19, 2025 | Hooks Corwin Dale | Chief Commercial Officer | Grant(A) | 313K | — | $0 |
| Dec 16, 2025 | Kanter Stacy J. | Director | Sell(S) | 43K | $0.11 | $5K |
| Oct 1, 2025 | Funtleyder Leslie D. | Chief Financial Officer, Director | Grant(A) | 150K | — | $0 |
| Jul 1, 2025 | Funtleyder Leslie D. | Chief Financial Officer, Director | Grant(A) | 150K | — | $0 |
| Jun 15, 2025 | Bailey Evan Prescott | Chief Medical Officer | Grant(A) | 300K | — | $0 |
| Jun 9, 2025 | Funtleyder Leslie D. | Chief Financial Officer, Director | Grant(A) | 150K | — | $0 |
| Jun 9, 2025 | Skyler Jay S | Director | Grant(A) | 200K | — | $0 |
| Jun 9, 2025 | Kanter Stacy J. | Director | Grant(A) | 200K | — | $0 |
| Jun 9, 2025 | Lerner Teena | Director | Grant(A) | 200K | — | $0 |
| Mar 24, 2025 | Chinoporos Constantine | See Remarks | Grant(A) | 350K | — | $0 |
| Mar 24, 2025 | Funtleyder Leslie D. | See Remarks, Director | Grant(A) | 350K | — | $0 |
| Mar 24, 2025 | Hooks Corwin Dale | Chief Commercial Officer | Grant(A) | 250K | — | $0 |
| Mar 4, 2025 | Chinoporos Constantine | See Remarks | Sell(S) | 447 | $0.44 | $197 |
| Mar 4, 2025 | Funtleyder Leslie D. | See Remarks, Director | Sell(S) | 15K | $0.44 | $6K |
| Mar 4, 2025 | Perfetti Riccardo | Chief Medical Officer | Sell(S) | 10K | $0.44 | $5K |
| Feb 6, 2025 | Chinoporos Constantine | See Remarks | Sell(S) | 28K | $0.61 | $17K |
| Feb 6, 2025 | Perfetti Riccardo | Chief Medical Officer | Sell(S) | 86K | $0.61 | $53K |
| Feb 6, 2025 | Funtleyder Leslie D. | See Remarks, Director | Sell(S) | 23K | $0.61 | $14K |
| Dec 19, 2024 | Funtleyder Leslie D. | See Remarks, Director | Grant(A) | 150K | — | $0 |
| Dec 19, 2024 | Funtleyder Leslie D. | See Remarks, Director | Grant(A) | 150K | — | $0 |
| Dec 19, 2024 | Johnson John | Executive Chairman, Director | Grant(A) | 500K | — | $0 |
| Dec 19, 2024 | Johnson John | Executive Chairman, Director | Grant(A) | 1.0M | — | $0 |
| Aug 22, 2024 | Perfetti Riccardo | Chief Medical Officer | Sell(S) | 23K | $5.83 | $132K |
| Aug 22, 2024 | Funtleyder Leslie D. | Chief Financial Officer, Director | Sell(S) | 14K | $5.83 | $79K |
| Aug 14, 2024 | Shendelman Shoshana | President and CEO, Director | Sell(S) | 120K | $5.93 | $709K |
| Aug 13, 2024 | Shendelman Shoshana | President and CEO, Director | Sell(S) | 357K | $6.18 | $2.2M |
| Aug 12, 2024 | Shendelman Shoshana | President and CEO, Director | Sell(S) | 300K | $5.98 | $1.8M |
| Aug 5, 2024 | Shendelman Shoshana | President and CEO, Director | Gift(G) | 748K | — | $0 |
| Aug 5, 2024 | Shendelman Shoshana | President and CEO, Director | Gift(G) | 748K | — | $0 |
| Jun 6, 2024 | Lerner Teena | Director | Grant(A) | 45K | — | $0 |
| Jun 6, 2024 | Marcus Joel S | Director | Grant(A) | 45K | — | $0 |
| Jun 6, 2024 | Skyler Jay S | Director | Grant(A) | 45K | — | $0 |
| Jun 6, 2024 | Kanter Stacy J. | Director | Grant(A) | 45K | — | $0 |
| Jun 6, 2024 | Funtleyder Leslie D. | Chief Financial Officer, Director | Sell(S) | 17K | $4.32 | $73K |
| Jun 6, 2024 | Perfetti Riccardo | Chief Medical Officer | Sell(S) | 22K | $4.32 | $95K |
| Jun 6, 2024 | Shendelman Shoshana | President and CEO, Director, 10% Owner | Sell(S) | 62K | $4.32 | $267K |
| Jun 5, 2024 | Alexandria Equities No. 7, LLC | 10% Owner | Sell(S) | 150K | $4.24 | $636K |
| Jun 4, 2024 | Alexandria Equities No. 7, LLC | 10% Owner | Sell(S) | 150K | $4.21 | $632K |
| Apr 12, 2024 | Hooks Corwin Dale | Chief Commercial Officer | Grant(A) | 300K | — | $0 |
| Mar 14, 2024 | Funtleyder Leslie D. | Chief Financial Officer, Director | Sell(S) | 29K | $5.39 | $155K |
| Mar 14, 2024 | Hansard Adam | Chief Commercial Officer | Sell(S) | 49K | $5.39 | $263K |
| Mar 14, 2024 | Perfetti Riccardo | Chief Medical Officer | Sell(S) | 111K | $5.39 | $597K |
| Mar 14, 2024 | Shendelman Shoshana | President and CEO, Director, 10% Owner | Sell(S) | 319K | $5.39 | $1.7M |
| Dec 28, 2023 | Chinoporos Constantine | See Remarks | Grant(A) | 300K | — | $0 |
| Dec 21, 2023 | Hansard Adam | Chief Commercial Officer | Grant(A) | 400K | — | $0 |
| Dec 21, 2023 | Perfetti Riccardo | Chief Medical Officer | Grant(A) | 450K | — | $0 |
| Dec 21, 2023 | Shendelman Shoshana | President and CEO, Director, 10% Owner | Grant(A) | 440K | — | $0 |
| Dec 21, 2023 | Shendelman Shoshana | President and CEO, Director, 10% Owner | Grant(A) | 1.1M | — | $0 |
| Dec 1, 2023 | Kanter Stacy J. | Director | Buy(P) | 30K | $2.18 | $65K |
| Nov 30, 2023 | Hansard Adam | Chief Commercial Officer | Sell(S) | 965 | $1.97 | $2K |
| Nov 30, 2023 | Perfetti Riccardo | Chief Medical Officer | Sell(S) | 2K | $1.97 | $3K |
| Nov 30, 2023 | Shendelman Shoshana | President and CEO, Director, 10% Owner | Sell(S) | 4K | $1.97 | $8K |
| Nov 29, 2023 | Alexandria Equities No. 7, LLC | 10% Owner | Other(J) | 575K | — | — |
| Nov 29, 2023 | Alexandria Equities No. 7, LLC | 10% Owner | Other(J) | 575K | — | — |
| Nov 20, 2023 | Funtleyder Leslie D. | Chief Financial Officer, Director | Grant(A) | 300K | — | $0 |
| Nov 3, 2023 | Alexandria Real Estate Equities, Inc. | 10% Owner | Sell(S) | 143K | $2.31 | $331K |
| Nov 2, 2023 | Alexandria Real Estate Equities, Inc. | 10% Owner | Sell(S) | 104K | $2.32 | $241K |
| Nov 1, 2023 | Alexandria Equities No. 7, LLC | 10% Owner | Sell(S) | 173K | $2.36 | $408K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).